Showing results (111-120 of 382) with videos related to
Sort By:
Pageof 39
Cell Systems|July 2, 2018
IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to ImmunotherapyJames C Chen, Rolando Perez-Lorenzo, Yvonne M Saenger, et al.European Urology Focus|July 30, 2017
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome AtlasMark W Ball, Michael A Gorin, Charles G Drake, et al.Cell Stem Cell|April 2, 2019
A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair GrowthEtienne C E Wang, Zhenpeng Dai, Anthony W Ferrante, et al.European Urology Focus|November 10, 2019
Evaluation of Incisional Negative Pressure Wound Therapy in the Prevention of Surgical Site Occurrences After Radical Cystectomy: A New Addition to Enhanced Recovery After Surgery ProtocolGregory A Joice, Giorgia Tema, Alice Semerjian, et al.Current Urology Reports|February 14, 2015
Tissue-engineered urinary conduitsMax Kates, Anirudha Singh, Hotaka Matsui, et al.Cell Reports. Medicine|October 8, 2021
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architectureHaoyang Mi, Trinity J Bivalacqua, Max Kates, et al.World Journal of Urology|January 24, 2019
Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytologyMohit Gupta, Niv Milbar, Giorgia Tema, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive TrialsMax Kates, Andres Matoso, Woonyoung Choi, et al.Cancer Cytopathology|October 9, 2023
Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot studyChristopher J VandenBussche, Christopher D Heaney, Max Kates, et al.Pageof 39